Catalyst Wire Dossier Catalyst Wire Dossier

Bifocal intraocular lens with low addition

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bifocal intraocular lens with low addition, covering 2025-06-12 to 2025-06-12. Get the full timeline:

Most recent: Clinical Trial Update: The Purpose is to Evaluate Visual Acuity for Distance, Intermediate and Near and Additionally Contrast Sensitivity at 25% and 10% of Illumination After Implantation of Trifocal IOL, Extended Range of Vision IOL, Bifocal IOL With Low Addition and Monofocal IOL [NA]

See pricing